Ionis receives U.S. FDA Breakthrough Therapy designation for zilganersen for Alexander disease (AxD)

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that the U.S. Food and Drug Administration (FDA) has granted ...
IEEE

Two-Step Compensation of Multiorder Dispersion Error for Hypersonic Targets’ SAR Imaging Covered by Plasma Sheath

Abstract: The objects reentering the Earth’s atmosphere with hypersonic speed will encounter unique challenges due to the plasma sheath, which significantly alters radar signal propagation ...